Short description
Lorantis develops products for the selective treatment of immunological and inflammatory diseases.
Description
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation.
The company is based in Cambridge, United Kingdom.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 1998
Closed on
November 5, 2005
Exited on
November 1, 2005
Non-profit?
No
Acquired?
No
Investors
Absolutely Noaccess, Noaccess, No Way, Nopepepe, Noaccessforu, Noaccessforu
Sign in for full access